OrbiMed’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.94M | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $58.9M | Sell |
|
|||||
|
2021
Q1 | $65.1M | Buy |
|
|||||
|
2020
Q4 | $56.1M | Sell |
|
|||||
|
2020
Q3 | $113M | Sell |
|
|||||
|
2020
Q2 | $231M | Sell |
|
|||||
|
2020
Q1 | $370M | Sell |
|
|||||
|
2019
Q4 | $465M | Sell |
|
|||||
|
2019
Q3 | $358M | Sell |
|
|||||
|
2019
Q2 | $443M | Sell |
|
|||||
|
2019
Q1 | $467M | Sell |
|
|||||
|
2018
Q4 | $256M | Sell |
|
|||||
|
2018
Q3 | $294M | Sell |
|
|||||
|
2018
Q2 | $294M | Buy |
|
|||||
|
2018
Q1 | $220M | Hold |
|
|||||
|
2017
Q4 | $135M | Hold |
|
|||||
|
2017
Q3 | $122M | Hold |
|
|||||
|
2017
Q2 | $93.5M | Buy |
|
|||||
|
2017
Q1 | $76.1M | Hold |
|
|||||
|
2016
Q4 | $55M | Buy |
|
|||||
|
2016
Q3 | $44M | Hold |
|
|||||
|
2016
Q2 | $29.1M | Buy |
|
|||||
|
2016
Q1 | $4.12M | Hold |
|
|||||
|
2015
Q4 | $4.07M | Hold |
|
|||||
|
2015
Q3 | $3.93M | Sell |
|
|||||
|
2015
Q2 | $25.6M | Hold |
|
|||||
|
2015
Q1 | $25.1M | Buy |
|